MRNA vs REGN: Which Stock is Better?

Side-by-side comparison of Moderna Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

MRNA

Moderna Inc

$53.57

REGN

Regeneron Pharmaceuticals Inc

$781.67

Key Metrics Comparison

MetricMRNAREGNWinner
Market Cap$20.93B$82.64BREGN
P/E RatioN/A18.83REGN
EPS (TTM)$N/A$41.51REGN
Revenue Growth-0.3%0.0%REGN
Gross Margin-105.8%44.6%REGN

Analyze MRNA

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MRNA or REGN a better investment?

Comparing MRNA and REGN: Moderna Inc has a market cap of $20.93B while Regeneron Pharmaceuticals Inc has $82.64B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MRNA and REGN?

MRNA (Moderna Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MRNA or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: MRNA or REGN?

REGN has higher revenue growth at 0.0% vs -0.3% for MRNA.

Which company is more profitable: MRNA or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -105.8% for MRNA.

Which is the larger company: MRNA or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $82.64B compared to $20.93B for MRNA.

Should I buy MRNA or REGN in 2026?

Both MRNA and REGN have investment merit. MRNA trades at $53.57 while REGN trades at $781.67. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MRNA and REGN stock?

Key differences: Market Cap ($20.93B vs $82.64B), P/E Ratio (N/A vs 18.8x), Revenue Growth (-0.3% vs 0.0%), Gross Margin (-105.8% vs 44.6%).

Popular Stock Comparisons